InhibitorSelect JAK/STAT Signaling Pathway Inhibitor Panel

A convenient panel containing 13 potent and selective inhibitors useful for the study of JAK/STAT signaling pathway. This panel contains the following inhibitors as well as 15 ml anhydrous DMSO for reconstitution:

A convenient panel containing 13 potent and selective inhibitors useful for the study of JAK/STAT signaling pathway. This panel contains the following inhibitors: 1 mg of Indirubin Derivative E804 (Cat. No. 402081); 500 µg of JAK Inhibitor I (Cat. No. 420099); 25 mg of JAK2 Inhibitor II (Cat. No. 420132); 5 mg of LY 294002 (Cat. No. 440202); 1 mg of PD 153035 (Cat. No. 234490); 1 mg of PP2 (Cat. No. 529573); 50 mg of SHP1/2 PTPase Inhibitor, NSC-87877 (Cat. No. 565851); 1 mg of STAT3 Inhibitor Peptide, Cell-Permeable (Cat. No. 573096); 10 mg of STAT3 Inhibitor III, WP1066 (Cat. No. 573097); 25 mg of STAT3 Inhibitor V, Stattic (Cat. No. 573099); 10 mg of STAT5 Inhibitior (Cat. No. 573108); 5 mg of AG490 (Cat. No. 658401) and 1 mg of U0126 (Cat. No. 662005). Also provided with 15 ml of anhydrous DMSO.

Packaged under inert gas

Following reconstitution, aliquot and freeze (-20°C) each inhibitor. Each inhibitor solution is stable for up to 3 months at -20°C.

Please refer to information provided on the CD for reconstitution information of individual inhibitors.

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Toxicity: Irritant (B)